Evidence map›Paper›PMID 40913135›Full record

ArticleThe EMBO journal2025

VH-replacement shapes the antibody repertoire by removing the genes of non-functional heavy-chains.

Harry N White, Peter Chovanec, Laura Biggins, Elise C French, Georgia Bullen, Simon Andrews, Anne E Corcoran

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Harry N WhiteThe Babraham Institute, Cambridge, CB22 3AT, UK. harry.white@babraham.ac.uk.ORCID http://orcid.org/0000-0001-8186-7789
Peter ChovanecDavid Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Laura BigginsThe Babraham Institute, Cambridge, CB22 3AT, UK.ORCID http://orcid.org/0000-0002-0975-1121
Elise C FrenchThe Babraham Institute, Cambridge, CB22 3AT, UK.
Georgia BullenThe Babraham Institute, Cambridge, CB22 3AT, UK.
Simon AndrewsThe Babraham Institute, Cambridge, CB22 3AT, UK.ORCID http://orcid.org/0000-0002-5006-3507
Anne E CorcoranThe Babraham Institute, Cambridge, CB22 3AT, UK.

Funding

Babraham Institute (BI) UKRI-BBSRCBiotechnology and Biological Sciences Research Council, UK (BBSRC) Industrial CASE PhD studentship 1520397Research in AEC's laboratory BBS/E/B/000C0427Research in AEC's laboratory BBS/E/B/000C0428
6 · The paper itself

Abstract

The diversity of antibodies underpins robust immune responses. During the formation of the antibody repertoire in early bone marrow B-cells, random antibody heavy-chain proteins are generated from recombined VH, DH, and JH gene segments. Many are non-functional and are negatively selected. To understand this process in normal mice, we have undertaken an in-depth analysis of heavy-chain selection at this pre-B cell transition. We find independent selection acting on three regions of the complementarity-determining region 3 (CDR3) antigen-binding site, with particularly heavy counter-selection against certain productive VH/JH combinations. This led us to hypothesise that VH-replacement, where the VH gene segment in an existing VDJ combination is replaced, targets productive VDJ rearrangements that code for non-functional heavy chains. We detect VH-replacement recombination products that closely follow the pattern of selection of functional and non-functional VDJ rearrangements. This reveals a physiological role for VH-replacement in the developmental release of B-cells that are stalled by non-functional heavy-chains. This leads to re-modelling of the restricted early VDJ repertoire toward the use of other VH gene segments throughout the IgH locus.

Indexed as

Immunoglobulin Heavy ChainsImmunoglobulin Variable RegionAnimalsB-LymphocytesComplementarity Determining RegionsMiceMice, Inbred C57BLPrecursor Cells, B-LymphoidV(D)J RecombinationComplementarity Determining RegionsImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionAntibody RepertoireB-cell DevelopmentVDJ-recombinationVH-replacement

Identifiers

PMID40913135
PMCPMC12528474

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.